Hoffmann-la Roche

This early-stage study tested a new medicine called RO7565020 in healthy people and those with chronic hepatitis B. The goal was to check safety and how the body processes the drug. The trial was stopped early, and results are not yet available.

This study looked at whether giving two immunotherapy drugs (tiragolumab and atezolizumab) before and after surgery, with or without chemotherapy, is safe and effective for people with early-stage non-small cell lung cancer. The trial planned to enroll 50 participants but was ter…

This study looked at adding atezolizumab (an immunotherapy) to cabozantinib (a targeted therapy) for people with advanced kidney cancer that got worse after prior immunotherapy. The goal was to see if the combination worked better than cabozantinib alone. The trial was terminated…

This study tested a drug called basmisanil in children aged 2 to 14 with Dup15q syndrome, a rare genetic condition that affects development. The goal was to see if the drug could improve daily living skills like communication and movement. The trial was stopped early after enroll…

This study looked at whether using digital health tools (like apps or online surveys) could help people receiving cancer treatment manage their symptoms and reduce visits to the doctor or hospital. About 49 adults with certain cancers were enrolled, but the study was stopped earl…